A ternary self-assembled molecular cluster for inhibiting MeIQx generation and its preparation method
By constructing a ternary self-assembled molecular cluster of modified gallic acid, lactose, and glutathione and encapsulating it in fish skin gelatin microgel, the problem of effectively inhibiting MeIQx generation in a wide temperature range and long thermal field was solved, achieving a highly efficient and stable MeIQx inhibition effect.
Patent Information
- Application Number
- CN202611503294.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-24
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies struggle to effectively suppress the formation of MeIQx in wide temperature ranges and long thermal fields. Conventional inhibitors have poor thermal stability and cannot block the formation pathway of MeIQx at the thermodynamic and electronic levels.
A ternary self-assembled molecular cluster, comprising modified gallic acid, lactose, and glutathione, was constructed and encapsulated in a fish skin gelatin microgel. Through multi-site synergistic effects, the precursors and intermediates of MeIQx were locked, and the frontier molecular orbital energy levels were modulated to form a composite system with thermal shielding function.
Achieving over 90% MeIQx inhibition efficiency within a wide processing temperature range of 120-200℃, significantly reducing the residual amount of MeIQx in food, improving the inhibition rate, and maintaining the stability of the active components.
Smart Images

Figure CN123100823A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of food processing technology, and in particular to a ternary self-assembled molecular cluster for inhibiting the generation of MeIQx and its preparation method. Background Technology
[0002] Thermal processing is one of the most widely used unit operations in food processing. Through complex thermochemical cascade processes such as Maillard reaction, Stryker degradation, and creatine cyclization, it endows food with unique color, aroma, and flavor qualities. However, these high-temperature-driven non-enzymatic reactions inevitably lead to the formation of heterocyclic amine compounds while generating flavor substances, among which MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) is the most representative. MeIQx is classified as a Group 2A carcinogen by the International Agency for Research on Cancer, and its mutagenicity is dozens of times that of benzo[a]pyrene. It is widely found in everyday foods such as grilled meats and fried surimi products. With the continued growth of global consumption of thermally processed foods, the dietary exposure risk of MeIQx has become a major issue spanning food science, toxicology, and public health.
[0003] For a long time, MeIQx control strategies have mainly focused on passive interventions such as adding exogenous antioxidants, controlling processing temperature, and removing precursors. However, conventional inhibitors (such as vitamin C and tea polyphenols) have poor thermal stability, rapidly degrading above 160°C, with inhibition rates generally below 50%, and their failure is particularly significant in the fluctuating heat fields of continuous industrial frying. The mechanisms of action of existing strategies remain at the phenomenological level, relying on free radical scavenging or single-target binding, and cannot intervene in the thermodynamic nature of MeIQx formation, that is, cannot change the activation energy, entropy-enthalpy balance, and spontaneous driving force of the reaction system, and lack a molecular delivery system that can maintain steady state in a wide temperature range (120-200°C) and long-term heat fields (continuous processing for several hours). Therefore, precise source control of MeIQx has not yet achieved a substantial breakthrough.
[0004] In recent years, advancements in supramolecular chemistry and quantum chemical computation have offered novel perspectives for addressing these issues. Nanoscale aggregates formed by the non-covalent self-assembly of molecular clusters exhibit emergent properties—the whole being greater than the sum of its parts—in fields such as catalysis and drug delivery due to their unique synergistic binding effects and designable electronic structures. Theoretically, if a food-grade molecular cluster could be constructed to simultaneously lock MeIQx precursors (creatinine, glucose, threonine) and key intermediates through multi-site synergistic effects, and by modulating the energy levels of the frontier molecular orbitals to raise the cyclization transition state barrier, it would be possible to block the reaction process from both thermodynamic and electronic perspectives. Furthermore, encapsulating this molecular cluster within a biomass microgel with thermal shielding capabilities could solve the problem of maintaining its activity during long-term high-temperature processing. However, currently, there are no reports on ternary self-assembled molecular clusters capable of simultaneously locking multiple MeIQx precursors and key intermediates, and on their preparation methods, which can dually block the MeIQx formation pathway from both thermodynamic and electronic perspectives by modulating the energy levels of the frontier molecular orbitals. Summary of the Invention
[0005] The purpose of this invention is to provide a ternary self-assembled molecular cluster that inhibits the generation of MeIQx and its preparation method, thereby solving the technical problems mentioned in the background art.
[0006] To achieve the above objectives, the technical solution adopted by the present invention is as follows: A ternary self-assembled molecular cluster for inhibiting the generation of MeIQx, comprising a ternary molecular cluster and a fish skin gelatin microgel, wherein the fish skin gelatin microgel encapsulates the ternary molecular cluster. The ternary molecular cluster comprises modified gallic acid, lactose, and glutathione, which are formed by non-covalent self-assembly.
[0007] Furthermore, the mass ratio of the ternary molecular clusters to the fish skin gelatin microgel is 1:4.
[0008] Furthermore, the molar ratio of the modified gallic acid, lactose, and glutathione is 2:3:1.
[0009] A method for preparing ternary self-assembled molecular clusters that suppress MeIQx generation includes the following steps: S1. Preparation of modified gallic acid: Gallic acid solution was placed under a UVC ultraviolet lamp with the lamp at a fixed vertical distance from the liquid surface. After continuous irradiation, modified gallic acid solution was obtained. S2, GSH-lactose@GA preparation: Glutathione, lactose and modified gallic acid were dissolved in deionized water at a molar ratio to prepare a mixed solution. After adjusting the pH, the solution was stirred under vacuum to carry out molecular self-assembly. The reaction monomers in the reaction solution were removed by ultrafiltration membrane. The retentate was freeze-dried to obtain ternary molecular cluster powder, denoted as GSH-lactose@GA. S3, MG@GSH-lactose@GA preparation: GSH-lactose@GA was dispersed in gelatin solution at a mass ratio, homogenized and emulsified at high speed, pH was adjusted with acetic acid to induce re-coagulation, genipin was added for cross-linking, centrifuged and washed 3 times with deionized water, and freeze-dried to obtain fish skin gelatin microgel slow-release cluster powder, denoted as MG@GSH-lactose@GA. S4. Sample preparation: During the chopping stage, fish skin gelatin microgel slow-release clusters are uniformly mixed into one of the shrimp paste, squid paste, and tilapia paste matrices to form a sample. The sample is then fried using a constant temperature continuous frying device and immediately cooled in an ice water bath after frying. S5. MeIQx Pretreatment and Detection: After pretreatment of the sample, the MeIQx content is detected. Furthermore, in step S1, the amount of gallic acid solution added is 2 mL, the concentration of gallic acid solution is 14 mmol / L, and the irradiation time is 6 h.
[0010] Furthermore, in step S2, the concentration of the mixture is 0.6 mol / L, and the pH is adjusted to 6.5.
[0011] Furthermore, in step S3, the mass ratio of GSH-lactose@GA to gelatin solution is 1:4, the concentration of acetic acid is 1.0 mol / L, and the pH is adjusted to 4.2.
[0012] Furthermore, in step S4, the frying temperature is 120-200℃ and the frying time is 2-10 minutes.
[0013] Furthermore, in step S5, the pretreatment is performed using QuEChERS combined with solid-phase extraction for extraction and purification, and the MeIQx content is detected using ultra-high performance liquid chromatography-tandem mass spectrometry.
[0014] This invention constructs a ternary self-assembled molecular cluster of glutathione, lactose, and gallic acid (GSH-lactose@GA), and encapsulates it in a fish gelatin microgel matrix to prepare the composite system MG@GSH-lactose@GA. This composite system can achieve a MeIQx inhibition efficiency of over 90% within a wide processing temperature range of 120-200℃.
[0015] The fish skin gelatin microgel sustained-release clusters prepared in this invention can be rapidly dispersed after being added to a fish paste matrix. They can form a multi-site stable supramolecular complex with MeIQx through hydrogen bonding and hydrophobic interactions. The fish skin gelatin microgel sustained-release clusters introduce gelatin peptide bonds to participate in synergistic coordination, resulting in a stronger locking and isolation effect on the reaction precursors and intermediates.
[0016] The microgel carrier of the present invention can protect the active ternary molecular clusters. The constructed microgel network has the dual functions of physical thermal barrier and controllable sustained release channel. This structure can effectively avoid high temperature degradation of active components and maintain the thermodynamic pathway reshaping effect under long-term heat treatment conditions, thereby achieving long-term stable inhibition of MeIQx.
[0017] The present invention, by adopting the above-described technical solution, has the following beneficial effects: This invention modifies and activates gallic acid by ultraviolet irradiation, then performs molecular self-assembly of glutathione, lactose, and modified gallic acid, followed by cross-linking of the ternary molecular clusters with fish gelatin to obtain fish skin gelatin microgel sustained-release clusters. This effectively inhibits the exponential accumulation of MeIQx with heating temperature and time, achieving a highly efficient, stable, and broad-spectrum heterocyclic amine inhibition effect over a wide temperature range. The invention also results in low MeIQx residue and high inhibition rate, further reducing MeIQx residue in food and improving inhibition efficiency. Attached Figure Description
[0018] Figure 1 This is a schematic diagram of the preparation process of the ternary self-assembled molecular cluster of the present invention; Figure 2 This is the MeIQx chromatographic distribution diagram of the present invention; Figure 3 This is a schematic diagram of the MeIQx content detection results of the present invention; Figure 4 This is a schematic diagram of the MeIQx suppression results of the present invention; Detailed Implementation To make the objectives, technical solutions, and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and preferred embodiments. However, it should be noted that many details listed in the specification are merely to provide the reader with a thorough understanding of one or more aspects of the present invention, and these aspects of the invention can be implemented even without these specific details.
[0019] Example 1 like Figure 1 As shown, a method for preparing ternary self-assembled molecular clusters that suppress MeIQx generation includes the following steps: S1. Take 2 mL of gallic acid solution with a concentration of mmol / L and place it in a microwave-safe environment with a wavelength of 225 nm and an average irradiance of 4540 μW / cm². 2Under a UVC ultraviolet lamp, with the lamp at a fixed vertical distance of 15cm from the liquid surface, a modified gallic acid solution was obtained after continuous irradiation for 6 hours. S2. Glutathione, lactose, and modified gallic acid were dissolved in deionized water at a molar ratio of 2:3:1 to prepare a 0.6 mol / L mixture. After adjusting the pH to 6.5, the mixture was stirred in a vacuum at 45°C for 24 h to carry out molecular self-assembly. The reactants in the reaction solution were removed by an ultrafiltration membrane with a molecular weight cutoff of 1000 Da. The retentate was freeze-dried to obtain a ternary molecular cluster powder, denoted as GSH-lactose@GA. S3. Fish skin gelatin was dissolved in deionized water in a 55℃ water bath to prepare a 6% (w / v) solution. GSH-lactose@GA was dispersed in the gelatin solution at a mass ratio of 1:4. The mixture was homogenized and emulsified at a high speed of 12000 r / min. The pH was adjusted to 4.2 with 1.0 mol / L acetic acid to induce re-coagulation. 0.8% (w / v) genipin was added for cross-linking for 2.5 h. The microgel dispersion was centrifuged at 5000 r / min for 20 min and washed three times with deionized water. After freeze-drying for 48 h, fish skin gelatin microgel sustained-release cluster powder was obtained, denoted as MG@GSH-lactose@GA. S4. In the chopping stage, the fish skin gelatin microgel slow-release clusters are uniformly mixed into the tilapia paste matrix and shaped into single 20g cylindrical samples. The samples are simulated by industrial frying conditions using a constant temperature continuous frying equipment. They are fried at temperatures of 120℃, 140℃, 160℃, 180℃, and 200℃ for 2 min, 4 min, 6 min, 8 min, and 10 min, respectively. The samples are then immediately cooled in an ice water bath after frying. S5. Sample pretreatment was performed using QuEChERS combined with solid-phase extraction for extraction and purification. The MeIQx content was detected using ultra-high performance liquid chromatography-tandem mass spectrometry.
[0020] Comparative Example 1 The control group (CK) without any added inhibitors was used, and the rest was the same as in Example 1.
[0021] Comparative Example 2 The GSH-lactose@GA group was formed by adding 0.6% by mass of ternary molecular clusters, and the rest was the same as in Example 1.
[0022] The detection method of this application is as follows: Extraction and purification were performed using QuEChERS combined with solid-phase extraction, and quantification was performed using ultra-high performance liquid chromatography-tandem mass spectrometry. The chromatographic column was ACQUITYUPLCBEHC18 (2.1×100mm, 1.7μm); the mobile phase was phase A: 0.1% formic acid aqueous solution, phase B: acetonitrile, gradient elution, flow rate 0.3mL / min, column temperature 40℃.
[0023] Mass spectrometry was performed in positive ion electrospray ionization mode with multiple reaction monitoring (MRM). The MeIQx suppression rate was calculated using the following formula: like Figure 2 As shown, chromatographic analysis of the samples obtained in Example 1 and Comparative Examples 1-2 revealed that the CK group exhibited high peak intensity, indicating a large amount of endogenous MeIQx generation from the tilapia surimi matrix. After treatment with GSH-lactose@GA, the MeIQx peak was significantly weakened, demonstrating significant inhibitory activity. MG@GSH-lactose@GA further reduced the intensity of the MeIQx characteristic peak, showing the best inhibition effect. Both composite systems effectively inhibited MeIQx generation, with the microgel encapsulation system exhibiting superior regulatory performance.
[0024] like Figure 3 As shown, the MeIQx content of the samples obtained in Example 1 and Comparative Examples 1-2 was detected. The results showed a comparison of the dynamic accumulation of MeIQx in the tilapia surimi matrix of the CK group, GSH-lactose@GA, and MG@GSH-lactose@GA at frying temperatures of 120-200℃. The MeIQx content in the CK group increased continuously with increasing frying temperature and heating time, indicating that the MeIQx content in the tilapia surimi of the CK group accumulated exponentially with heating time and temperature. The MeIQx generation at 200℃ was 2.6-3.3 times that at 120℃ (p < 0.05), indicating that MeIQx generation is strongly temperature-dependent and thermodynamically spontaneous. The results of MeIQx residue quantification showed that, across the entire test temperature range, the MeIQx residue in the GSH-lactose@GA group was below 5.41 μg / kg; while MG@GSH-lactose@GA could further reduce the MeIQx residue to below 2.69 μg / kg, with a significant difference between the two groups (p < 0.05). Both GSH-lactose@GA and MG@GSH-lactose@GA could significantly inhibit MeIQx accumulation (p < 0.05). Among the two treatment groups, MG@GSH-lactose@GA had the best inhibition effect over a wide temperature range, and the system had the lowest MeIQx residue.
[0025] like Figure 4As shown, calculations of the MeIQx inhibition rate of the MeIQx content in Example 1 and Comparative Example 2 revealed the inhibition rates of the two clusters on MeIQx in the tilapia surimi matrix under frying temperatures of 120-200℃ and dynamic heat treatment conditions of 2-10 min. Both molecular clusters exhibited extremely strong inhibitory activity across the entire test temperature range, with inhibition rates consistently above 90%, and the inhibitory effect showed no significant temperature decay (p < 0.05). Within the full temperature range of 120-200℃ and heating time of 2-10 min, GSH-lactose@GA stably exerted an inhibitory effect in the tilapia surimi matrix, with an overall inhibition rate of approximately 90.04%-92.99%. The MG@GSH-lactose@GA complex further enhanced the inhibition efficiency, maintaining a stable inhibition rate of 93.56%-95.85% under all experimental conditions. The difference between the two groups was significant, with the MG@GSH-lactose@GA complex showing significantly better inhibitory performance than GSH-lactose@GA (p < 0.05). The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A ternary self-assembled molecular cluster that inhibits the formation of MeIQx, characterized in that: It includes ternary molecular clusters and fish skin gelatin microgels, wherein the fish skin gelatin microgels encapsulate the ternary molecular clusters; The ternary molecular cluster comprises modified gallic acid, lactose, and glutathione, which are formed by non-covalent self-assembly.
2. The ternary self-assembled molecular cluster of claim 1, wherein: The mass ratio of the ternary molecular clusters to the fish skin gelatin microgel is 1:
4.
3. A ternary self-assembled molecular cluster for inhibiting MeIQx generation according to claim 1, characterized in that: The molar ratio of the modified gallic acid, lactose, and glutathione is 2:3:
1.
4. The method for preparing a ternary self-assembled molecular cluster for inhibiting the formation of MeIQx according to any one of claims 1-3, characterized in that: Includes the following steps: S1. Preparation of modified gallic acid: Gallic acid solution was placed under a UVC ultraviolet lamp with the lamp at a fixed vertical distance from the liquid surface. After continuous irradiation, modified gallic acid solution was obtained. S2, GSH-lactose@GA preparation: Glutathione, lactose and modified gallic acid were dissolved in deionized water at a molar ratio to prepare a mixed solution. After adjusting the pH, the solution was stirred under vacuum to carry out molecular self-assembly. The reaction monomers in the reaction solution were removed by ultrafiltration membrane. The retentate was freeze-dried to obtain ternary molecular cluster powder, denoted as GSH-lactose@GA. S3, MG@GSH-lactose@GA preparation: GSH-lactose@GA was dispersed in gelatin solution at a mass ratio, homogenized and emulsified at high speed, pH was adjusted with acetic acid to induce re-coagulation, genipin was added for cross-linking, centrifuged and washed 3 times with deionized water, and freeze-dried to obtain fish skin gelatin microgel slow-release cluster powder, denoted as MG@GSH-lactose@GA. S4. Sample preparation: During the chopping stage, the fish skin gelatin microgel slow-release clusters are evenly mixed into the fish paste matrix and shaped. The sample is then fried using a constant temperature continuous frying device and immediately cooled in an ice water bath after frying. S5. MeIQx Pretreatment and Detection: After pretreatment of the sample, the MeIQx content is detected.
5. The method for preparing a ternary self-assembled molecular cluster that inhibits MeIQx generation according to claim 4, characterized in that: In step S1, the amount of gallic acid solution added is 2 mL, the concentration of gallic acid solution is 14 mmol / L, and the irradiation time is 6 h.
6. The method for preparing a ternary self-assembled molecular cluster that inhibits MeIQx generation according to claim 4, characterized in that: In step S2, the concentration of the mixture is 0.6 mol / L, and the pH is adjusted to 6.
5.
7. The method for preparing a ternary self-assembled molecular cluster that inhibits MeIQx generation according to claim 4, characterized in that: In step S3, the concentration of acetic acid is 1.0 mol / L, and the pH is adjusted to 4.
2.
8. The method for preparing a ternary self-assembled molecular cluster that inhibits MeIQx generation according to claim 4, characterized in that: In step S4, the frying temperature is 120-200℃ and the frying time is 2-10 minutes.
9. The method for preparing a ternary self-assembled molecular cluster that inhibits MeIQx generation according to claim 4, characterized in that: In step S5, the pretreatment is carried out by QuEChERS combined with solid phase extraction for extraction and purification, and the MeIQx content is detected by ultra-high performance liquid chromatography-tandem mass spectrometry.
